Herman Verrelst
Angel investor in Leuven
Leuven, Flanders
Herman Verrelst, Angel investor in Leuven is an active investor based in Leuven, Flanders. This profile covers what Herman Verrelst backs, at which stage, and how founders can reach out in 2026.
Mr. Herman Verrelst is the Founding Partner and serves as Senior Advisor of HERAN Partners. He serves as Board Member at Nuclivision. He is a Co-Founder and Serves as Chief Executive Officer at Gynaia. He serves as a Board Member at Aspect Analytics. He served as Chairman at Aspect Analytics. He is an Angel Investor. He serves as Executive Chairman at Biocartis. He served as a Board Member at iCometrix. He was appointed as an independent Chairman of the board effective as of 24 April 2023. He served as chief executive officer and independent board director of the Company between August 2017 and April 2023. He is a seasoned executive and serial entrepreneur with a proven international commercial track record in molecular diagnostics. Before joining Biocartis, he held the position of vice president and general manager of the genomics and clinical applications division of Agilent Technologies, a global leader in life sciences, diagnostics, and applied chemical markets. He joined Agilent following Agilent's acquisition of Cartagena, a spin-off of Katholieke Universiteit Leuven (Belgium) focused on software solutions for clinical genetics and molecular oncology, of which he was CEO and founder. Prior to that, he was CEO of Medicim as well as founder and CEO of DATA4s.
- Investor type
- Angel
- Stages
- Early Stage Venture
- Invests in
- MedTech & Medical DevicesHealthcare & BiotechBiotech & PharmaSaaS & EnterpriseFintech
- Location
- Leuven, Flanders
- Typical check
- $500K
- Past investments
- 11
Notable investments
UgenTecFOx BiosystemsCartageniaEpsynomicsnuclivisionMedviaBiovia
icometrixMedicim NVHow to reach Herman Verrelst
Angels and operators like Herman Verrelst reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.
Reach active investors like this one
About this profile
This profile is part of Round Funded, an investor database and outreach platform for founders. It covers 60,000+ active VCs, angels, family offices and accelerators with verified contacts, lets you send pitches from your own Gmail, and includes a free Data Room for your raise. How this data is built.
Cite this page
Round Funded. "Herman Verrelst." Round Funded investor database, updated September 9, 2026.
Stable URL, it will not change: https://www.roundfunded.com/en/investor/herman-verrelst-111475-2
Frequently Asked Questions
What does Herman Verrelst invest in?
Herman Verrelst invests in MedTech & Medical Devices, Healthcare & Biotech, Biotech & Pharma and SaaS & Enterprise, typically at Early Stage Venture. Match your sector and stage, then reach out with a personalized pitch.
What stage does Herman Verrelst invest at?
Herman Verrelst typically invests at Early Stage Venture. Lead with traction that fits the stage when you reach out.
What is Herman Verrelst's typical check size?
Herman Verrelst typically writes checks around $500K. Use it as a signal for whether your raise fits their stage.
How do founders reach investors like this?
Round Funded lists active investors with verified, professional contact details for signed-up founders. Filter by sector, stage and location, then send a personalized pitch from your own inbox.
What is Round Funded?
Round Funded is an investor database and outreach platform for startup founders. It lists 60,000+ active investors with verified contacts, filtered to recent investment activity, and lets founders send personalized pitches from their own Gmail, track replies, and share a free Data Room. Round+ starts at $99 per month with a 3-day trial.